Oculoplastics-ASOPRS

Teprotumumab may improve ocular surface disease in patients with TED

Ocular surface symptoms are a common complaint for patients with thyroid eye disease (TED). Data from a new study presented at the ASOPRS 52nd Annual Fall Scientific Symposium found that teprotumumab significantly improved ocular surface disease measurements and visual functioning-related quality of life in patients with TED. Researchers analyzed 16...